MedTrace Logo

Game-Based Education and Treatment Adherence in Type 2 Diabetes

NCT07195188 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2025-09-26

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if an education program can help lower anxiety and improve treatment follow-up in adults with type 2 diabetes. The main questions it aims to answer are:

Does attending the education program lower anxiety levels?

Does it help people better follow their diabetes treatment plan?

Researchers will compare two groups:

Education group: Participants who attend the program.

Control group: Participants who do not attend the program.

Participants will:

Be randomly assigned to either the education group or the control group.

Attend four weekly sessions, each lasting two hours, over one month (education group only).

Complete surveys before and after the program, including the Beck Anxiety Scale (to measure anxiety) and the Patient Compliance Scale for Type 2 Diabetes Mellitus Treatment (to measure treatment follow-up).

Conditions

Interventions

BEHAVIORAL

"Let's Learn Diabetes" Game-Based Education

Participants in the experimental group will receive diabetes education using the "Let's Learn Diabetes" board game. The program consists of four weekly sessions, each lasting two hours, over one month. The intervention is designed to improve diabetes knowledge, reduce anxiety, and enhance treatment adherence among patients with Type 2 Diabetes Mellitus on insulin therapy.

BEHAVIORAL

Traditional Diabetes Education

Participants in the control group will receive standard diabetes education through traditional lecture-based presentations. The education schedule matches the experimental group with four weekly sessions, each lasting two hours, over one month.

Sponsors & Collaborators

  • Usak State Hospital

    collaborator OTHER

  • Izmir Tinaztepe University

    lead OTHER

Principal Investigators

  • Gönül düzgün, phd · Izmir Tinaztepe University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-05
Primary Completion
2024-05-03
Completion
2024-11-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07195188 on ClinicalTrials.gov